Delirium
Jo Ellen Wilson(VA Tennessee Valley Healthcare System), E. Wesley Ely(Vanderbilt University)
Cited by 1,145
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
The Immunopathogenesis of Sepsis in Elderly Patients
|Clinical Infectious Diseases|2005|486
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis
|Critical Care Medicine|2003|283
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
|Nature Immunology|2023|281
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis*
|Critical Care Medicine|2003|226